Vol 2006, No 72 (2006)

Table of Contents

Cartoons

Ready Steady Bio jpg
Business Review Editor

Deal Trackers

Diquafosol Abstract pdf
Business Review Editor

Research & Development

Boehringer Ingelheim’s Bonanza Month Abstract pdf
Business Review Editor

Features

Therapy Focus: Hypoxia-Selective Agents as Anticancer Drugs Abstract pdf
Business Review Editor
Deal Making Spotlights on Big Pharma Abstract pdf
Business Review Editor
Astellas Enters into Yet Another Agreement Abstract pdf
Business Review Editor
Abraxis and AstraZeneca Exchange Agreements Abstract pdf
Business Review Editor

Licensing

Chelsea Augments its Pipeline Abstract pdf
Business Review Editor
Immunomedics Relights its Therapeutic Potential Abstract pdf
Business Review Editor

General

IPOs: Still the Exit Strategy of Choice? Abstract
Business Review Editor
ExonHit Therapeutics SA Abstract
Business Review Editor

Mergers & Acquisitions

AstraZeneca to Acquire Cambridge Antibody Technology Abstract pdf
Business Review Editor

Distribution & Marketing

Kos to Market SkyePharma’s Flutiform™ Abstract pdf
Business Review Editor

Business Commentaries

Let Knowledge Flow Abstract html
Fintan Walton


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.